Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × Bevacizumab × Clear all

NCT00473590 2017-06-14

AMBER

Phase 2 Completed

102 enrolled 13 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00022607 2013-06-24

Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell